Novabay Pharmaceuticals Inc (NBY) Stock to return to profitability in the near future

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. The research report from Laidlaw has reiterated the stock to Buy, with a price target set at $8. The stock was initiated by ROTH Capital, who disclosed in […]

Is Novabay Pharmaceuticals Inc (NBY) Stock a good investment?

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. The research report from Laidlaw has reiterated the stock to Buy, with a price target set at $8. The stock was initiated by ROTH Capital, who disclosed in […]

It’s not the right time to quit: Novabay Pharmaceuticals Inc (NBY) Stock

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]

Faced with a depressed economy, Novabay Pharmaceuticals Inc (NBY) Stock offers an opportunity

Ladenburg Thalmann raised the price target for the Novabay Pharmaceuticals Inc (AMEX:NBY) stock to “a Buy”. The rating was released on September 18, 2019, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]